GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Current Accrued Expense

Longevity Biomedical (Longevity Biomedical) Current Accrued Expense : $0.00 Mil (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Current Accrued Expense?

Longevity Biomedical's Current Accrued Expense for the quarter that ended in . 20 was $0.00 Mil.


Longevity Biomedical Current Accrued Expense Historical Data

The historical data trend for Longevity Biomedical's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Current Accrued Expense Chart

Longevity Biomedical Annual Data
Trend
Current Accrued Expense

Longevity Biomedical Semi-Annual Data
Current Accrued Expense

Longevity Biomedical Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Longevity Biomedical Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Longevity Biomedical (Longevity Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines